Open help menu
Live Webinar
AAGP 2026 Geriatric Psychiatry Board Review Course

Late-Life Depression, Bereavement, and Suicide

James Ellison
|

Pricing

Information

Date & Time

Learning Objectives

Participants will be able to:

  • Describe how the assessment and treatment of Major Depressive Disorder in Later Life (Late Life Depression or LLD) differs in older adults.

  • List evidence-based pharmacologic and nonpharmacologic treatments for Late Life Depression and describe the benefits and adverse effects of each.

  • Differentiate grief from complicated grief and from bereavement and discuss evidence-based treatments for complicated grief.

  • Identify the distinctive epidemiology, risk factors, and methods of late-life suicide.

Educational Goal

MDD is a highly treatable disorder in older adults, not a “normal part of aging”. Age influences demographics, etiology, presentation, assessment, acute and maintenance treatment, and outcome. Bereavement and suicide are additional syndromes of clinical importance in our aging patients.

Description

This comprehensive, high-yield educational activity is designed to enhance clinical competence in geriatric psychiatry and support clinicians preparing for the geriatric psychiatry board examination. Led by expert, board-certified faculty with extensive experience in clinical practice and education, the course delivers a structured review of core diagnostic and therapeutic topics relevant to the evaluation and management of psychiatric disorders in older adults. Through evidence-based content and interactive board-style self-assessment questions, participants will reinforce key concepts, identify learning needs, and integrate best practices into patient care.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

James Ellison